Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples